Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein pathway suppressor 2 pseudogene 2 (GPS2P2) is a non-coding pseudogene related to the protein-coding GPS2 gene. It retains high sequence similarity to GPS2, but does not produce a functional protein or have validated direct biological function. Recent computational models suggest pseudogenes like GPS2P2 may play regulatory roles, such as acting as microRNA decoys or modulating parental gene expression in ceRNA networks, by sharing sequences and regulatory elements. However, GPS2P2 itself is not recognized as a therapeutic target, biomarker, or drug-interacting entity. The protein-coding gene GPS2, in contrast, is involved in cancer, inflammation, and metabolic regulation, but these properties do not directly extend to GPS2P2 based on current biological data and annotation.[3][1][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein pathway suppressor 2 pseudogene 2 (GPS2P2).